Symbicort [budesonide/formoterol] in chronic obstructive pulmonary disease

Trial Profile

Symbicort [budesonide/formoterol] in chronic obstructive pulmonary disease

Phase of Trial: Phase III

Latest Information Update: 27 Jan 2011

At a glance

  • Drugs Budesonide/formoterol (Primary)
  • Indications Chronic obstructive pulmonary disease
  • Focus Therapeutic Use
  • Acronyms SYMBOL
  • Sponsors AstraZeneca
  • Most Recent Events

    • 11 Mar 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top